
Common name
(1R,3aR,4aS,8aR,9S,9aS)-1-methyl-9-vinyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-3-one
IUPAC name
(1R,3aR,4aS,8aR,9S,9aS)-1-methyl-9-vinyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-3-one
SMILES
C(=C)C1C2C(OC(=O)C2CC3C1CCCC3)C
Common name
(1R,3aR,4aS,8aR,9S,9aS)-1-methyl-9-vinyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-3-one
IUPAC name
(1R,3aR,4aS,8aR,9S,9aS)-1-methyl-9-vinyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-3-one
SMILES
C(=C)C1C2C(OC(=O)C2CC3C1CCCC3)C
INCHI
InChI=1S/C15H22O2/c1-3-11-12-7-5-4-6-10(12)8-13-14(11)9(2)17-15(13)16/h3,9-14H,1,4-8H2,2H3/t9-,10+,11+,12-,13-,14+/m1/s1
FORMULA
C15H22O2

Common name
(1R,3aR,4aS,8aR,9S,9aS)-1-methyl-9-vinyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-3-one
IUPAC name
(1R,3aR,4aS,8aR,9S,9aS)-1-methyl-9-vinyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f]isobenzofuran-3-one
Molecular weight
234.334
clogP
2.874
clogS
-2.294
Frequency
0.0003
HBond Acceptor
2
HBond Donor
0
Total PolarSurface Area
26.3
Number of Rings
3
Rotatable Bond
1
Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
---|---|---|---|---|
FDBD01636 | Vorapaxar |
![]() |
Platelet Aggregation Inhibitors; Antithrombotic Agents; Blood and Blood Forming Organs; Platelet Aggregation Inhibitors Excl. Heparin; | Vorapaxar is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). It is usually co-administered with acetylsalicylic acid (ASA) and/or clopidogrel, and should therefore be administered as an addition to these medications as it has not been studied alone. |
FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
---|---|---|---|---|---|
3ebl_ligand.mol2 | 3ebl | 0.741379 | -9.58 | C1C[C@H](O)[C@@]2([C@H]3[C@H](C(=O)O)[C@]45[C@H]([C@]13OC2=O)CC[C@H](C4)C(=C)C5)C | 25 |
2dbl_ligand.mol2 | 2dbl | 0.68 | -9.84 | C1C[C@H](OC(=O)CCC(=O)O)C[C@@H]2CC[C@@H]3[C@@H]([C@@]12C)CC[C@]1([C@H]3CC[C@@H]1C(=O)C)C | 31 |
2a2g_ligand.mol2 | 2a2g | 0.659574 | -7.69 | C1[C@@H](CC[C@]2([C@@H]1O2)C)C(=C)C | 12 |
5d1r_ligand.mol2 | 5d1r | 0.644444 | -8.07 | C(CCCCCCCCC)CC(=O)OC(C)C | 18 |
2fxu_ligand_3_460.mol2 | 2fxu | 0.625 | -6.20 | C[C@H]1[C@H](CC[C@H](CC(=O)/C=C/C)O1)C | 14 |
2fxu_ligand_2_81.mol2 | 2fxu | 0.625 | -5.93 | C([C@H]1CC[C@@H](CO1)C)C(=O)/C=C/C | 13 |